L-methylfolate (Deplin®): A new medical food therapy as adjunctive treatment for depression

Issues in Mental Health Nursing

Volumn 32, Issue 2, 2011, Pages 142-143

  Roman, Marian W ^a   Bembry, Fay H ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; 5-METHYLTETRAHYDROFOLATE; TETRAHYDROFOLIC ACID DERIVATIVE;

ARTICLE; DEPRESSION; DIET SUPPLEMENTATION; FOLIC ACID DEFICIENCY; FOOD AND DRUG ADMINISTRATION; HUMAN; MULTIMODALITY CANCER THERAPY; UNITED STATES;

COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; DIETARY SUPPLEMENTS; FOLIC ACID DEFICIENCY; HUMANS; TETRAHYDROFOLATES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 79955683671     PISSN: 01612840     EISSN: 10964673     Source Type: Journal    
DOI: 10.3109/01612840.2010.541975     Document Type: Article

References (12)

1. Alpert, J. E., & Fava, M. (1997). Nutrition and depression: The role of folate. Nutrition Review, 55(5), 145-149. (Pubitemid 27331379)
2. Coppen, A., & Bolander-Gouaille, C. (2005). Treatment of depression: Time to consider folic acid and vitamin B12. Psychopharmacology, 19(1), 59-65.
3. Deplin R. (2010). Product information. Retrieved December 13, 2010 from http://www.deplin.com/DeplinFacts
4. Farah, A. (2009). The role of L-methylfolate in depressive disorders. CNS Spectrums, 14(1 Suppl 2), 2-7.
5. Food and Drug Administration, 2010, http://www.fda.gov/ foodGuidanceComplianceRegulatoryInformation/GuidanceDocuments/MedicalFoods/ucm 054048.htm
6. Ginsberg, L. (2010, July). Evidence for L-methylfolate in combination with an antidepressant at initiation of therapy. Podium presentation at the Mood and Anxiety Disorders, Current Psychiatry/American Academy of Clinical Psychiatrists Conference, Chicago, IL. (Sponsored presentation.) Retrieved from http://www.currentpsychiatry.com/videos/index.html
7. Godfrey, P. S., Toone, B. K., Carney,M.W., Flynn, T. G., Bottiglieri, T., Laundy, M., Reynolds, E. H. (1990). Enhancement of recovery from psychiatric illness by methylfolate. Lancet, 336(8712), 392-395. (Pubitemid 20252436)
8. Kelly, C. B., McDonnell, A. P., Johnston, T. G., Mulholland, C., Cooper, S. J., McMaster, D., Whitehead, A. S. (2004). The MTHFR C677T Polymorphism is associated with depressive episodes in patients from Northern Ireland. Journal of Psychopharmacology, 18, 567-571. (Pubitemid 39665125)
9. Papakostas, G. I., Petersen, T., & Lebowitz, B. D. (2005). The relationship between serum folate, vitamin B12, and homcysteine levels in major depressive disorder and the timing of improvement with fluoxetine. International Journal of Neuropsychopharmacology, 8, 523-528. (Pubitemid 41400882)
10. Shelton, R. (2009). The role of L-methylfolate in depressive disorders: Commentary. CNS Spectrums, 14(1 Suppl 2), 8.
11. Stahl, S. M. (2007). Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent. CNS Spectrums, 12(10), 739-744. (Pubitemid 350072170)
12. Stahl, S. M. (2008). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (3rd ed.). Cambridge, UK: Cambridge University Press.